Abe Miranda
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Abe Miranda has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Alyssa Finlay
Division of TB Elimination, Centers for Disease Control and Prevention, Gaborone, Botswana
1 shared publication - Joey Lancaster
Tuberculosis Epidemiology and Intervention Research Unit, Medical Research Council, 1 Soutpansberg Road, Pretoria 0001, South Africa
1 shared publication - Karin Weyer
Global Tuberculosis Programme, World Health Organization, Geneva, Switzerland
1 shared publication - Martie van der Walt
Tuberculosis Epidemiology and Intervention Research Unit, Medical Research Council, 1 Soutpansberg Road, Pretoria 0001, South Africa
1 shared publication - Timothy H. Holtz
Thailand Ministry of Public Health - U.S. Centers for Disease Control and Prevention Collaboration, Nonthaburi, Thailand; Division of HIV/AIDS Prevention, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia.
1 shared publication
Latest Publications
- Open Access
- 20 January 2012
- Published by Springer Nature in BMC Public Health
- Vol. 12 (1) , 56
Patient- and provider-level risk factors associated with default from tuberculosis treatment, South Africa, 2002: a case-control study
Persons who default from tuberculosis treatment are at risk for clinical deterioration and complications including worsening drug resistance and death. Our objective was to identify risk factors associated with tuberculosis (TB) treatment default in South Africa.
- 20 January 2012
- Published by Springer Nature in BMC Public Health
- Vol. 12 (1) , 56
Open AccessPatient- and provider-level risk factors associated with default from tuberculosis treatment, South Africa, 2002: a case-control study
Persons who default from tuberculosis treatment are at risk for clinical deterioration and complications including worsening drug resistance and death. Our objective was to identify risk factors associated with tuberculosis (TB) treatment default in South Africa.